TheraRadar
← Back
Data updated: Mar 29, 2026

BH

OncologyInfectious DiseaseImmunology
Generics

BH is a generic drug manufacturer focused on Oncology, Infectious Disease, Immunology.

1976
Since
1
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 44%
0 drugs Phase 3: 17 Phase 2: 31 Phase 1: 57
Infectious Disease 20%
0 drugs Phase 3: 12 Phase 2: 11 Phase 1: 14
Immunology 19%
0 drugs Phase 3: 14 Phase 2: 7 Phase 1: 12
Ophthalmology 9%
0 drugs Phase 3: 7 Phase 2: 3 Phase 1: 4
Cardiovascular 8%
0 drugs Phase 3: 3 Phase 2: 10 Phase 1: 3

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Oncology, Cardiovascular, Immunology, Ophthalmology
Merck big-pharma
Oncology, Infectious Disease, Cardiovascular, Immunology
Baxter specialty
Infectious Disease, Cardiovascular, Oncology, Ophthalmology
AbbVie big-pharma
Immunology, Oncology, Infectious Disease, Ophthalmology
Johnson & Johnson big-pharma
Oncology, Immunology, Infectious Disease, Cardiovascular